[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Singapore Health Care Industry Report - H2, 2013

January 2014 | 35 pages | ID: S301F578DF0EN
Emerging Markets Direct

US$ 475.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report profiles Singapore’s health care industry, including a survey of the landscape of leading players such as IHH Healthcare, Raffles Medical Group (RMG), Health Management International (HMI), and Healthway Medical Corporation (HMC). Most of these firms also have a regional presence, particularly in China and India. Singapore’s United States-accredited institutions have helped make the country’s average life span the second-longest in the region (after Japan) and attract thousands of medical tourists each year, mostly from Indonesia and Malaysia.

Singapore’s health care system is internationally recognized and was ranked sixth out of 191 countries and first in Asia on health systems, hence allowing the country to be well poised to benefit from global trends. In 2012, Singapore’s health care services industry had a total of 4,600 establishments with over 70,000 employees working in the industry. Singapore’s public health care sector is managed by the MOH and affordable basic medical services are provided to all Singaporeans through subsidized medical services. The country aims to build 17 new and replacement nursing homes by 2016.

The health care services industry recorded operating receipts of SGD 10.53 billion in 2012, an increase of 8.55% over the previous year. According to the Singapore Tourism Board, about 885,000 foreign patients were treated in Singapore in 2012, up 15% over the previous year.

Key Points:
  • Among the leading health care players in Singapore are IHH Healthcare Berhad, Raffles Medical Group, Health Management International Ltd, and Healthway Medical Corporation Ltd. IHH Healthcare is the largest healthcare provider in Singapore and one of the largest in Asia Pacific, with a presence in Malaysia, India, and China, among other countries.
  • Singapore’s health facilities are accredited by the U.S.-based JCI.
  • In 2012, Indonesians accounted for the largest share of medical tourists, at 47.2%, followed by Malaysians (11.5%), Bangladeshis (5%) and Vietnamese (4.1%).
  • In Asia, Singapore’s average life expectancy (at 82 years) trails only that of Japan (at 83).
1. INDUSTRY PROFILE

1.1 Health care in Asia Pacific
1.2 General overview of Singapore
1.3 Singapore health care industry
  1.3.1 Social development
  1.3.2 Health care services

2. MARKET TRENDS AND OUTLOOK

2.1 Financing approach
2.2 SingaporeMedicine
  2.2.1 Medical tourism
  2.2.2 Economic Development Board (EDB)
2.3 Customer-Centric Initiative (CCI)
2.4 National Electronic Health Records System (NEHR)

3. LEADING PLAYERS AND COMPARATIVE MATRIX

3.1 Leading players
  3.1.1 IHH Healthcare Berhad (IHH)
  3.1.2 Raffles Medical Group Limited (RMG)
  3.1.3 Health Management International Limited (HMI)
  3.1.4 Healthway Medical Corporation Limited (HMC)
3.2 Comparative matrix
3.3 SWOT analysis

4. TABLES AND CHARTS

Table 1: Life Expectancy of Selected Asian Countries
Table 2: General Economic Statistics (2001–12)
Table 3: Key Indicators of Health Services (2010–12)
Table 4: Hospital and Public Sector Clinics (2007–12)
Table 5: Hospital Admissions and Public Sector Outpatient Attendances (2007–12)
Table 6: Average Hospital Inpatient Bill Size Table, Public Hospitals—Medical Specialties (January to December 2012)
Table 7: Average Hospital Inpatient Bill Size Table, Private Hospitals—Medical Specialties (January to December 2012)
Table 8: Medical Centers that Obtained the Joint Commission International (JCI) Accreditation
Table 9: Cost of Medical Treatment in Singapore
Table 10: Healthcare Organisations Participating in CCI
Table 11: Operational Highlights—IHH
Table 12: Financial Highlights of the Leading Players (Latest financial quarter)
Table 13: Financial Highlights of the Leading Players (Annual results)
Chart 1: Global Pharmaceutical Market by Region in 2012
Chart 2: Global Pharmaceutical Market by Region in 2008
Chart 3: Population and Growth Rate (2007–12)
Chart 4: Social Development in Healthcare Industry (2007–12)
Chart 5: Beds Occupancy Rates
Chart 6: Revenue Contribution in FY2012—IHH
Chart 7: EBITDA Contribution in FY2012—IHH
Chart 8: Revenue by Segment—RMG (2011–12)
Chart 9: Revenue by Segment—HMI (2011–12)
Chart 10: Revenue by Segment—HMC (2011–12)


More Publications